Harvard Business Review

AUGUST 17, 2012

Cipla, an India-based producer of low cost antiretroviral drugs (ARVs) is one of the biggest success stories in the pharma industry. What's more, these are markets that traditional developed market firms are increasingly targeting for their own growth goals. and other traditionally developed markets. laç Ticaret Anonim ?irketi

Company 12

Company Pharmaceuticals Business Model Fixed Costs 12

Harvard Business Review

JULY 27, 2017

Among the 30 top companies in seven of the largest industries, almost half had a VC-fueled accelerator in 2015, up from just 2% in 2010. And the fixed cost from “touchpoint-to-pilot” are immense. In essence, the venture client, instead of equity, buys the technology of a startup when it is still a venture to do so.

Venture Capitalist 8

Venture Capitalist Meyer Innovation Fixed Costs 8

Harvard Business Review

SEPTEMBER 9, 2015

During an economic crisis, the exaggerated decline in orders can be especially damaging to upstream suppliers that have high fixed costs tied to production assets. Since 2000, the Chinese economy has been growing at an increasing rate — from 6% per year in 2000 to 12% per year in 2010.

Supply Chain 8

Supply Chain Retail Crisis Operations 8

Harvard Business Review

MARCH 18, 2013

We didn't want to burden the organization with fixed costs. Almost everything had to be free, and the few things we paid for had to be scalable so that the unit costs would eventually approach zero. Software development" and "hardware" are bad words. This removed the biggest bottleneck to innovation — us.

Budgeting 9

Budgeting Software Entrepreneur Fixed Costs 9

Harvard Business Review

APRIL 6, 2016

For example, in 2010, Corelio and Concentra, two European media companies, established Coldset Printing Partners, a joint venture (JV) for their newspaper printing assets. Taiwan, and South Korea, respectively — agreed to fund a novel technology development program at ASML, a leading equipment manufacturer based in the Netherlands.

Co-Opetition 8

Co-Opetition Operations Cost Technology 8

Harvard Business Review

FEBRUARY 24, 2015

A 2010 meta-analysis detailed many of the different issues that make divestiture so hard to evaluate consistently. In parallel, it reduced its fixed costs by restructuring its industrial footprint and overhead structure; increasing sales, marketing, and R&D expenditures in targeted areas; and dramatically reducing working capital.

Chemicals 8

Chemicals How To Kahneman Reputation 8

Harvard Business Review

NOVEMBER 6, 2013

From my experience heading Scotland’s National Health Service from 2010 until last August (and before as its director of health care policy and strategy), I know that such constraints can unleash innovations that will lead to better care — and better health — for communities. Working under a fixed-cost ceiling was, of course, difficult.

Health Care 8

Health Care Constraint Budgeting Quality 8